CSAR Subsidiary Regulations: China Finalizes the Regulations for Cosmetic Adverse Reaction Monitoring
Feb 22, 2022
On Feb. 21, 2022, China NMPA issued the Management of Cosmetic Adverse Reaction Monitoring, which is China’s first regulation specifically for the management of cosmetic adverse reaction monitoring.
Following the first public consultation on Sept. 28, 2020, and the second public consultation on Sept. 29, 2021, China National Medical Products Administration (NMPA) released the finalized Measures for the Management of Cosmetic Adverse Reaction Monitoring (the Measures) on Feb. 21, 2022, which will take effect on Oct. 1, 2022. 1
Please Log in
or Sign up
(FREE) to read the full content.
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by email@example.com
Copyright: unless otherwise stated all contents of this website are ©2023 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact firstname.lastname@example.org